Ruijuan Gao
NHC Key Laboratory Of Biotechnology For Microbial Drugs, Chinese Academy Of Medical Sciences & Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Combined therapy with ALK inhibitors and a novel EGFR-targeting antibody‒drug conjugate as a strategy for ALK-rearranged non-small cell lung cancers.
Journal: Oncogenesis
Published: September 08, 2025
Discovery of highly potent dual GSPT1/BRD4 degraders with anti-AML activity.
Journal: European journal of medicinal chemistry
Published: December 09, 2024
A Nerve-Fibroblast Axis in Mammalian Lung Fibrosis.
Journal: bioRxiv : the preprint server for biology
Published: September 24, 2024
A new TROP2-targeting antibody-drug conjugate shows potent antitumor efficacy in breast and lung cancers.
Journal: NPJ precision oncology
Published: August 30, 2023
A recombinant scFv antibody-based fusion protein that targets EGFR associated with IMPDH2 downregulation and its drug conjugate show therapeutic efficacy against esophageal cancer.
Journal: Drug delivery
Published: April 13, 2022
Macrophage-derived netrin-1 drives adrenergic nerve-associated lung fibrosis.
Journal: The Journal of clinical investigation
Published: January 23, 2020
Glycol Chitosan Engineered Autoregenerative Antioxidant Significantly Attenuates Pathological Damages in Models of Age-Related Macular Degeneration.
Journal: ACS nano
Published: May 03, 2017
A Gelatinases-targeting scFv-based Fusion Protein Shows Enhanced Antitumour Activity with Endostar against Hepatoma.
Journal: Basic & clinical pharmacology & toxicology
Published: September 01, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026